Coagulation defects do not predict blood product requirements during liver transplantation

Transplantation

Volumn 85, Issue 7, 2008, Pages 956-962

  Massicotte, Luc ^a   Beaulieu, Danielle ^a   Thibeault, Lynda ^a   Roy, Jean Denis ^a   Marleau, Denis ^a   Lapointe, Réal ^a   Roy, André ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Coagulation defects; Liver transplantation; Survival; Transfusion

Indexed keywords

ADULT; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING DISORDER; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY; PLASMA TRANSFUSION; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; CREATININE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLATELET COUNT; REOPERATION; RETROSPECTIVE STUDIES;

EID: 42149167288     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318168fcd4     Document Type: Article

References (32)

1. Butler P, Israel L, Nusbacher J, et al. Blood transfusion in liver transplantation. Transfusion 1985; 25: 120.
2. Massicotte L, Lenis S, Thibeault L, et al. Reduction of blood product transfusions during liver transplantation. Can J Anesth 2005; 52: 545.
3. ASA guidelines. Available at: http://www.asahq.org/ publicationsandservices/transfusion.pdf.
4. Planinsic RM, van der Meer J, Tests G, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 2005; 11: 895.
5. Lodge JP, Jonas S, Jones RM, et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 2005; 11: 973.
6. Massicotte L, Sassine M-P, Lenis S, et al. Transfusion predictors in liver transplant. Anesth Analg 2004; 98: 1245.
7. Ozier Y, Pessione F, Samain E, et al. French study group on blood transfusion in liver transplantation. Institutional variability in transfusion practice for liver transplantation. Anesth Analg 2003; 97: 671.
8. Cacciarelli TV, Keeffe EB, Moore DH, et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 1999; 134: 25.
9. Ramos E, Dalmau A, Sabaté A, et al. Intraoperative red blood cell transfusion in liver transplantation: Influence on patient outcome, prediction of requirements, and measure to reduce them. Liver Transpl 2003; 9: 1320.
10. Massicotte L, Sassine M-P, Lenis S, et al. Survival rate changes with transfusion of blood products during liver transplantation. Can J Anesth 2005; 52: 148.
11. Hendriks HG, van der Merr J, de Wolf JT, et al. Intraoperative blood transfusion requirement is the main determinant of early surgical reintervention after orthotopic liver transplantation. Transpl Int 2005; 17: 673.
12. Reyle-Hahn M, Rossaint R. Coagulation techniques are not important in directing blood product transfusion during liver transplantation. Liver Transpl 1997; 6: 659.
13. Dupont J, Messiant F, Declerck N, et al. Liver transplantation without the use of fresh frozen plasma. Anesth Analg 1996; 83: 681.
14. Tripodi A, Mannucci PM. Abnormalities of hemostasis in chronic liver disease: Reappraisal of their clinical significance and need for clinical and laboratory research. J. Hepatol 2007; 46: 727.
15. Caldwell SH, Hoffman M, Lisman T, et al. Coagulation in liver disease group. Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management. Hepatology 2006; 44: 1039.
16. Ewe K. Bleeding after liver biopsy does not correlate with indices of perphenal coagulation. Dig Dis Sci 1981; 26: 388.
17. Boks AL, Brommer EJ, Schalm SE, et al. Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage. Hepatology 1986; 6: 79.
18. Trotter JF, Brimhall B, Arjal R, et al. Specific laboratory methodologies achieve higher model for end-stage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004; 10: 995.
19. Tripodi A, Salerno F, Chantarangkull V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation test. Hepatology 2005; 41: 553.
20. Massicotte L, Lenis S, Thibeault L, et al. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006; 12: 117.
21. Contandriopoulos A-P, Champagne F, Potvin L, et al. Savoir préparer une recherche: la définir, la structurer, la financer, chapitre 2. Les Presses de l'Université de Montréal 1990, pp 37-38.
22. Glantz SA, Slinker BK. Primer of applied regression and analysis of variance. New York, McGraw-Hill Inc. 1990, p 514.
23. Tripodi A, Premignami M, Chantarangkull, et al. Thrombin Generation in patients with cirrhosis: The role of platelets. Hepatology 2006; 44: 440.
24. Frasco PE, Poterack KA, Hentz JG, et al. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: Relationship to model of end-stage liver disease score and baseline coagulation status. Anesth Analg 2005; 101: 30.
25. Massicotte L, Thibeault L, Beaulieu D, et al. Evaluation of cell salvage autotransfusion utility during liver transplantation. HPB 2007; 9: 52.
26. Molenaar IQ, Warnaar N, Groen H, et al. Efficacy and safety of antifibrinolytic drugs in liver transplantation: A systematic review and meta-analysis. Am J Transplant 2007; 7: 185.
27. Mangano DT, Tudor C, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354: 4.
28. Baubillier E, Cherqui D, Dominique C, et al. A fatal thrombotic complication during liver transplantation after aprotinin administration. Transplantation 1994; 57: 1664.
29. Lentschener C, Roche K, Ozier Y. A review of aprotinin in orthrotopic liver transplantation: Can its harmful effects offset its beneficial effects. Anesth Analg 2005; 100: 1248.
30. Varotti G, Grazi GL, Vetrone G, et al. Causes of early acute graft failure after liver transplantation: Analysis of a 17-year single-centre experience. Clin Transplant 2005; 19: 492.
31. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, ed. The liver and portal hypertension. Philadelphia, Saunders 1964, pp 50-64.
32. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2002; 33: 4645.